Tudor Investment Corp
TAK icon

Tudor Investment Corp’s Takeda Pharmaceutical TAK Stock Holding History

Tudor Investment Corp’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,724
Closed -$267K – 2768
2023
Q4 		$267K Buy
+18,724
New +$266K ﹤0.01% 2080
2023
Q3 		– Sell
-170,818
Closed -$2.68M – 2858
2023
Q2 		$2.68M Buy
170,818
+59,877
+54% +$981K 0.03% 731
2023
Q1 		$1.83M Buy
+110,941
New +$1.77M 0.03% 843
2020
Q1 		– Sell
-437,923
Closed -$8.64M – 1322
2019
Q4 		$8.64M Buy
437,923
+1,451
+0.3% +$27.8K 0.39% 37
2019
Q3 		$7.51M Buy
+436,472
New +$7.55M 0.26% 70
2019
Q2 		– Sell
-1,279,098
Closed -$26.1M – 1328
2019
Q1 		$26.1M Buy
+1,279,098
New +$25.7M 1.08% 10

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tudor Investment Corp's TAK Position: Q1 2024 in Review

Tudor Investment Corp sold out of Takeda Pharmaceutical (TAK) in Q1 2024, closing a stake of 18,724 shares — an estimated $267K sold.

Tudor Investment Corp first reported a position in TAK in Q1 2019 and held it in 6 quarters. The position peaked at $26.1M in Q1 2019. 313 funds tracked by Wall St. Rank hold TAK as of Q1 2024.

  • Tudor Investment Corp reported no remaining Takeda Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 18,724 Takeda Pharmaceutical shares in Q1 2024, an estimated $267K.
  • Tudor Investment Corp first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 6 quarters.
  • Tudor Investment Corp's Takeda Pharmaceutical position peaked at $26.1M in Q1 2019.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2024.

Based on Tudor Investment Corp's 13F filing for Q1 2024, filed 15 May 2024.